DGKζ-IN-4 treatment led to a statistically significant increase in both apoptosis and, unexpectedly, necrosis across the tested AML cell lines (Figure 2F, Supplementary Figure S4). The gene discussed is CD44; the disease is acute myeloid leukemia.